CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer

Luigi Racioppi, Erik Nelson, Wei Huang, Debarati Mukherjee, Scott A. Lawrence, William Lento, Anna Maria Masci, Yiquin Jiao, Sunghee Park, Brian York, Yaping Liu, Amy E. Baek, David H. Drewry, William J. Zuercher, Francesca R. Bertani, Luca Businaro, Joseph Geradts, Allison Hall, Anthony R. Means, Nelson ChaoChing yi Chang, Donald P. McDonnell

Research output: Contribution to journalArticle

Abstract

Tumor-associated myeloid cells regulate tumor growth and metastasis, and their accumulation is a negative prognostic factor for breast cancer. Here we find calcium/calmodulin-dependent kinase kinase (CaMKK2) to be highly expressed within intratumoral myeloid cells in mouse models of breast cancer, and demonstrate that its inhibition within myeloid cells suppresses tumor growth by increasing intratumoral accumulation of effector CD8+ T cells and immune-stimulatory myeloid subsets. Tumor-associated macrophages (TAMs) isolated from Camkk2−/− mice expressed higher levels of chemokines involved in the recruitment of effector T cells compared to WT. Similarly, in vitro generated Camkk2−/− macrophages recruit more T cells, and have a reduced capability to suppress T cell proliferation, compared to WT. Treatment with CaMKK2 inhibitors blocks tumor growth in a CD8+ T cell-dependent manner, and facilitates a favorable reprogramming of the immune cell microenvironment. These data, credential CaMKK2 as a myeloid-selective checkpoint, the inhibition of which may have utility in the immunotherapy of breast cancer.

Original languageEnglish (US)
Article number2450
JournalNature communications
Volume10
Issue number1
DOIs
StatePublished - Dec 1 2019

Fingerprint

T-cells
regulators
Myeloid Cells
breast
Tumors
tumors
cancer
Breast Neoplasms
T-Lymphocytes
effectors
cells
macrophages
Macrophages
Neoplasms
mice
Calcium-Calmodulin-Dependent Protein Kinase Kinase
Growth
calmodulin
Cellular Microenvironment
Cell proliferation

ASJC Scopus subject areas

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)

Cite this

CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer. / Racioppi, Luigi; Nelson, Erik; Huang, Wei; Mukherjee, Debarati; Lawrence, Scott A.; Lento, William; Masci, Anna Maria; Jiao, Yiquin; Park, Sunghee; York, Brian; Liu, Yaping; Baek, Amy E.; Drewry, David H.; Zuercher, William J.; Bertani, Francesca R.; Businaro, Luca; Geradts, Joseph; Hall, Allison; Means, Anthony R.; Chao, Nelson; Chang, Ching yi; McDonnell, Donald P.

In: Nature communications, Vol. 10, No. 1, 2450, 01.12.2019.

Research output: Contribution to journalArticle

Racioppi, L, Nelson, E, Huang, W, Mukherjee, D, Lawrence, SA, Lento, W, Masci, AM, Jiao, Y, Park, S, York, B, Liu, Y, Baek, AE, Drewry, DH, Zuercher, WJ, Bertani, FR, Businaro, L, Geradts, J, Hall, A, Means, AR, Chao, N, Chang, CY & McDonnell, DP 2019, 'CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer', Nature communications, vol. 10, no. 1, 2450. https://doi.org/10.1038/s41467-019-10424-5
Racioppi, Luigi ; Nelson, Erik ; Huang, Wei ; Mukherjee, Debarati ; Lawrence, Scott A. ; Lento, William ; Masci, Anna Maria ; Jiao, Yiquin ; Park, Sunghee ; York, Brian ; Liu, Yaping ; Baek, Amy E. ; Drewry, David H. ; Zuercher, William J. ; Bertani, Francesca R. ; Businaro, Luca ; Geradts, Joseph ; Hall, Allison ; Means, Anthony R. ; Chao, Nelson ; Chang, Ching yi ; McDonnell, Donald P. / CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer. In: Nature communications. 2019 ; Vol. 10, No. 1.
@article{7e0a49b649574c80bbf5c6075ff5198e,
title = "CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer",
abstract = "Tumor-associated myeloid cells regulate tumor growth and metastasis, and their accumulation is a negative prognostic factor for breast cancer. Here we find calcium/calmodulin-dependent kinase kinase (CaMKK2) to be highly expressed within intratumoral myeloid cells in mouse models of breast cancer, and demonstrate that its inhibition within myeloid cells suppresses tumor growth by increasing intratumoral accumulation of effector CD8+ T cells and immune-stimulatory myeloid subsets. Tumor-associated macrophages (TAMs) isolated from Camkk2−/− mice expressed higher levels of chemokines involved in the recruitment of effector T cells compared to WT. Similarly, in vitro generated Camkk2−/− macrophages recruit more T cells, and have a reduced capability to suppress T cell proliferation, compared to WT. Treatment with CaMKK2 inhibitors blocks tumor growth in a CD8+ T cell-dependent manner, and facilitates a favorable reprogramming of the immune cell microenvironment. These data, credential CaMKK2 as a myeloid-selective checkpoint, the inhibition of which may have utility in the immunotherapy of breast cancer.",
author = "Luigi Racioppi and Erik Nelson and Wei Huang and Debarati Mukherjee and Lawrence, {Scott A.} and William Lento and Masci, {Anna Maria} and Yiquin Jiao and Sunghee Park and Brian York and Yaping Liu and Baek, {Amy E.} and Drewry, {David H.} and Zuercher, {William J.} and Bertani, {Francesca R.} and Luca Businaro and Joseph Geradts and Allison Hall and Means, {Anthony R.} and Nelson Chao and Chang, {Ching yi} and McDonnell, {Donald P.}",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41467-019-10424-5",
language = "English (US)",
volume = "10",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer

AU - Racioppi, Luigi

AU - Nelson, Erik

AU - Huang, Wei

AU - Mukherjee, Debarati

AU - Lawrence, Scott A.

AU - Lento, William

AU - Masci, Anna Maria

AU - Jiao, Yiquin

AU - Park, Sunghee

AU - York, Brian

AU - Liu, Yaping

AU - Baek, Amy E.

AU - Drewry, David H.

AU - Zuercher, William J.

AU - Bertani, Francesca R.

AU - Businaro, Luca

AU - Geradts, Joseph

AU - Hall, Allison

AU - Means, Anthony R.

AU - Chao, Nelson

AU - Chang, Ching yi

AU - McDonnell, Donald P.

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Tumor-associated myeloid cells regulate tumor growth and metastasis, and their accumulation is a negative prognostic factor for breast cancer. Here we find calcium/calmodulin-dependent kinase kinase (CaMKK2) to be highly expressed within intratumoral myeloid cells in mouse models of breast cancer, and demonstrate that its inhibition within myeloid cells suppresses tumor growth by increasing intratumoral accumulation of effector CD8+ T cells and immune-stimulatory myeloid subsets. Tumor-associated macrophages (TAMs) isolated from Camkk2−/− mice expressed higher levels of chemokines involved in the recruitment of effector T cells compared to WT. Similarly, in vitro generated Camkk2−/− macrophages recruit more T cells, and have a reduced capability to suppress T cell proliferation, compared to WT. Treatment with CaMKK2 inhibitors blocks tumor growth in a CD8+ T cell-dependent manner, and facilitates a favorable reprogramming of the immune cell microenvironment. These data, credential CaMKK2 as a myeloid-selective checkpoint, the inhibition of which may have utility in the immunotherapy of breast cancer.

AB - Tumor-associated myeloid cells regulate tumor growth and metastasis, and their accumulation is a negative prognostic factor for breast cancer. Here we find calcium/calmodulin-dependent kinase kinase (CaMKK2) to be highly expressed within intratumoral myeloid cells in mouse models of breast cancer, and demonstrate that its inhibition within myeloid cells suppresses tumor growth by increasing intratumoral accumulation of effector CD8+ T cells and immune-stimulatory myeloid subsets. Tumor-associated macrophages (TAMs) isolated from Camkk2−/− mice expressed higher levels of chemokines involved in the recruitment of effector T cells compared to WT. Similarly, in vitro generated Camkk2−/− macrophages recruit more T cells, and have a reduced capability to suppress T cell proliferation, compared to WT. Treatment with CaMKK2 inhibitors blocks tumor growth in a CD8+ T cell-dependent manner, and facilitates a favorable reprogramming of the immune cell microenvironment. These data, credential CaMKK2 as a myeloid-selective checkpoint, the inhibition of which may have utility in the immunotherapy of breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=85066637422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066637422&partnerID=8YFLogxK

U2 - 10.1038/s41467-019-10424-5

DO - 10.1038/s41467-019-10424-5

M3 - Article

C2 - 31164648

AN - SCOPUS:85066637422

VL - 10

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

IS - 1

M1 - 2450

ER -